05-03-2021 12:37 PM | Source: Reuters
Pfizer in talks with India over expedited approval for COVID-19 vaccine
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
NEW DELHI - Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.
"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
Latest News
Commodity Research Evening Track by Kotak Securities
Quote on Nifty by Rupak De, Senior Technical Analyst...
FIIs stood as net buyers in equities as per November...
Quote on Rupee by Jateen Trivedi, VP Research Analys...
Market Quote : State Election Results Boost Market S...
Daily Market Analysis : Markets began the week on a ...
Daily Market Commentary : Nifty50 Gaps Up, Rises 315...
Inflation to ease, economic growth to accelerate in ...
Demand for entry-level talent surges 59 pc in India`...
Sensex closes up by 992 points, Adani Ports, L&T top...
